Wuhan Huoshenshan Hospital
Welcome,         Profile    Billing    Logout  
 19 Trials 
7 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wang, Fu-Sheng
NCT05224960: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)

Recruiting
2
140
RoW
UC-MSCs, Placebo(solution without UC-MSCs)
Beijing 302 Hospital, Chinese PLA General Hospital, Shanghai Changzheng Hospital, LanZhou University, Jin Yin-tan Hospital, Hainan Hospital of Chinese PLA General Hospital, Vcanbio Cell and Gene Engineering Corp., Ltd., Third Affiliated Hospital, Sun Yat-Sen University, Xinjiang Kashi Area Number 1 Hospital
Decompensated Cirrhosis
06/25
06/27
KY-2023-2-6-2, NCT06416709: Stem Cell Treatment for Lung Injury Caused by Major Infectious Diseases

Recruiting
1/2
80
RoW
mesenchymal stem cells, KY-2023-2-6-2, saline
Cell Energy Life Sciences Group Co. LTD, Beijing 302 Hospital
Lung Injury
05/26
05/26
NCT05939167: Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

Recruiting
1/2
150
RoW
mesenchymal stem cell, umbilical cord derived MSCs, saline
Cell Energy Life Sciences Group Co. LTD, Beijing 302 Hospital, Shenzhen Third People's Hospital, Fifth Hospital of Shijiazhuang City, Beijing YouAn Hospital
AIDS
07/25
07/26
NCT04518774: Allogeneic "Gammadelta T Cells (γδ T Cells)" Cell Immunotherapy in Phase 1 Hepatocellular Carcinoma Clinical Trial

Recruiting
1
8
RoW
Ex-vivo expanded allogeneic γδT cells
Beijing 302 Hospital, Chinese Academy of Medical Sciences, Beijing GD Initiative Cell Therapy Technology Co., Ltd.
Hepatocellular Carcinoma
06/21
08/21
NCT05227846: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)

Recruiting
1
12
RoW
Human Umbilical Cord-derived Mesenchymal Stem Cells
Beijing 302 Hospital, VCANBIO Cell & Gene Engineering Corporation, Ltd
Decompensated Cirrhosis
06/24
03/25
Shi, Lei
NCT05224960: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)

Recruiting
2
140
RoW
UC-MSCs, Placebo(solution without UC-MSCs)
Beijing 302 Hospital, Chinese PLA General Hospital, Shanghai Changzheng Hospital, LanZhou University, Jin Yin-tan Hospital, Hainan Hospital of Chinese PLA General Hospital, Vcanbio Cell and Gene Engineering Corp., Ltd., Third Affiliated Hospital, Sun Yat-Sen University, Xinjiang Kashi Area Number 1 Hospital
Decompensated Cirrhosis
06/25
06/27
NCT05227846: Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)

Recruiting
1
12
RoW
Human Umbilical Cord-derived Mesenchymal Stem Cells
Beijing 302 Hospital, VCANBIO Cell & Gene Engineering Corporation, Ltd
Decompensated Cirrhosis
06/24
03/25

Download Options